Dr. Xiuning Le, M.D., Ph.D.
Claim this profileM D Anderson Cancer Center
Area of expertise
Lung Cancer
Xiuning Le, M.D., Ph.D. has run 9 trials for Lung Cancer. Some of their research focus areas include:
Cancer
Xiuning Le, M.D., Ph.D. has run 3 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
M D Anderson Cancer Center
The University Of Texas M.D. Anderson Cancer Center
Clinical Trials Xiuning Le, M.D., Ph.D. is currently running
Balstilimab
for Oropharyngeal Cancer
This study aims to leverage this unique property of HPV+ OPC to detect possible minimal residual disease represented by persistent viral detection after the completion of definitive treatment. The study will offer adjuvant immune therapy to patients with persistent viral detection and evaluate the clearance of viral load. It will evaluate the rate of viral clearance with immune therapy and establish the link between viral clearance and long-term disease control.
Recruiting
1 award
Phase 2
NVL-330
for Advanced Lung Cancer
Phase 1a/1b dose escalation and expansion study designed to evaluate the safety and tolerability of NVL-330, determine the recommended Phase 2 dose (RP2D), and evaluate the antitumor activity in patients with advanced or metastatic HER2-altered NSCLC. Phase 1a dose escalation is designed to assess the safety and tolerability of NVL-330 and to select the candidate RP2D(s) and, if applicable, the MTD. Phase 1b expansion is designed to further evaluate the overall safety and tolerability of the candidate RP2D(s) of NVL-330 and to determine the RP2D of NVL-330 in patients with advanced or metastatic HER2 mutant NSCLC.
Recruiting
1 award
Phase 1
2 criteria
More about Xiuning Le, M.D., Ph.D.
Clinical Trial Related
4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Xiuning Le, M.D., Ph.D. has experience with
- Osimertinib
- Cisplatin
- Docetaxel
- Tepotinib
- OSI-774
- Cemiplimab
Breakdown of trials Xiuning Le, M.D., Ph.D. has run
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Xiuning Le, M.D., Ph.D. specialize in?
Xiuning Le, M.D., Ph.D. focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved EGFR positive patients, or patients who are Stage III.
Is Xiuning Le, M.D., Ph.D. currently recruiting for clinical trials?
Yes, Xiuning Le, M.D., Ph.D. is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Xiuning Le, M.D., Ph.D. has studied deeply?
Yes, Xiuning Le, M.D., Ph.D. has studied treatments such as Osimertinib, Cisplatin, Docetaxel.
What is the best way to schedule an appointment with Xiuning Le, M.D., Ph.D.?
Apply for one of the trials that Xiuning Le, M.D., Ph.D. is conducting.
What is the office address of Xiuning Le, M.D., Ph.D.?
The office of Xiuning Le, M.D., Ph.D. is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.